The influence of the distal resection margin length on local recurrence and long-term survival in patients with rectal cancer after chemoradiotherapy and sphincter- preserving rectal resection

被引:16
作者
Grosek, Jan [1 ]
Velenik, Vaneja [2 ]
Edhemovic, Ibrahim [3 ]
Omejc, Mirko [1 ,4 ]
机构
[1] Univ Med Ctr Ljubljana, Dept Abdominal Surg, Zaloska Cesta 7, SI-1000 Ljubljana, Slovenia
[2] Inst Oncol Ljubljana, Dept Radiotherapy, Ljubljana, Slovenia
[3] Inst Oncol Ljubljana, Dept Surg, Ljubljana, Slovenia
[4] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
关键词
rectal cancer; distal resection margin; chemoradiotherapy; local recurrence; survival; COMBINED-MODALITY THERAPY; INTRAMURAL SPREAD; MESORECTAL EXCISION; ADEQUATE LENGTH; PHASE-II; TRIAL; RADIOTHERAPY; MULTICENTER; CENTIMETER; CARCINOMA;
D O I
10.1515/raon-2016-0030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Low recurrence rates and long term survival are the main therapeutic goals of rectal cancer surgery. Complete, margin-negative resection confers the greatest chance for a cure. The aim of our study was to determine whether the length of the distal resection margin was associated with local recurrence rate and long-term survival. Patients and methods. One hundred and nine patients, who underwent sphincter-preserving resection for locally advanced rectal cancer after preoperative chemoradiotherapy between 2006 and 2010 in two tertiary referral centres were included in the study. Distal resection margin lengths were measured on formalin-fixed, pinned specimens. Characteristics of patients with distal resection margin < 8 mm (Group I, n = 27), 8-20 mm (Group II, n = 31) and > 20 mm (Group III, n = 51) were retrospectively analysed and compared. Median (range) follow-up time in Group I was 89 (51-111), in Group II 83 (57-111) and in Group III 80 (45-116) months (p = 0.326), respectively. Results. Univariate survival analysis showed that distal resection margin length was not statistically significantly associated with overall survival or local recurrence rate (p > 0.05). In a multiple Cox regression analysis, after adjusting for pathologic T and N stage (yT, yN), distal resection margin length was still not statistically significantly associated with overall survival. Conclusions. Our study shows that close distal resection margins can be accepted as oncologically safe for sphincter-preserving rectal resections after preoperative chemoradiotherapy.
引用
收藏
页码:169 / 177
页数:9
相关论文
共 33 条
  • [21] Acceptance of a 5-mm distal bowel resection margin for rectal cancer: is it safe?
    Rutkowski, A.
    Nowacki, M. P.
    Chwalinski, M.
    Oledzki, J.
    Bednarczyk, M.
    Liszka-Dalecki, P.
    Gornicki, A.
    Bujko, K.
    [J]. COLORECTAL DISEASE, 2012, 14 (01) : 71 - 78
  • [22] A PROSPECTIVE-STUDY OF THE LENGTH OF THE DISTAL MARGIN AFTER LOW ANTERIOR RESECTION FOR RECTAL-CANCER
    SONDENAA, K
    KJELLEVOLD, KH
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1990, 5 (02) : 103 - 105
  • [23] What is the Significance of the Circumferential Margin in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy?
    Trakarnsanga, Atthaphorn
    Gonen, Mithat
    Shia, Jinru
    Goodman, Karyn A.
    Nash, Garrett M.
    Temple, Larissa K.
    Guillem, Jose G.
    Paty, Philip B.
    Garcia-Aguilar, Julio
    Weiser, Martin R.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (04) : 1179 - 1184
  • [24] Treatment of locally advanced rectal cancer: Controversies and questions
    Trakarnsanga, Atthaphorn
    Ithimakin, Suthinee
    Weiser, Martin R.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (39) : 5521 - 5532
  • [25] Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
    van Gijn, Willem
    Marijnen, Carrie A. M.
    Nagtegaal, Iris D.
    Kranenbarg, Elma Meershoek-Klein
    Putter, Hein
    Wiggers, Theo
    Rutten, Harm J. T.
    Pahlman, Lars
    Glimelius, Bengt
    van de Velde, Cornelis J. H.
    [J]. LANCET ONCOLOGY, 2011, 12 (06) : 575 - 582
  • [26] Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
    Velenik, Vaneja
    Ocvirk, Janja
    Music, Maja
    Bracko, Matej
    Anderluh, Franc
    Oblak, Irena
    Edhemovic, Ibrahim
    Brecelj, Erik
    Kropivnik, Mateja
    Omejc, Mirko
    [J]. RADIATION ONCOLOGY, 2011, 6
  • [27] Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer
    Velenik, Vaneja
    Oblak, Irena
    Anderluh, Franc
    [J]. RADIATION ONCOLOGY, 2010, 5
  • [28] Post-treatment surveillance in colorectal cancer
    Velenik, Vaneja
    [J]. RADIOLOGY AND ONCOLOGY, 2010, 44 (03) : 135 - 141
  • [29] Locally recurrent rectal cancer: treatment options
    Velenik, Vaneja
    [J]. RADIOLOGY AND ONCOLOGY, 2009, 43 (03) : 144 - 151
  • [30] VERNAVA AM, 1992, SURG GYNECOL OBSTET, V175, P333